February 22, 2016

RTOG 0815: Closure Notice dated February 22, 2016; the trial has met its target accrual and will close to accrual at 5 PM ET March 7, 2016.

RTOG 1216: Study Memorandum for Temporary Closure dated February 22, 2016; Phase II component met accrual and will close for protocol-specified analyses at 5 PM ET today.

NRG-BR002: Amendment 1, Version Date: January 12, 2016

NSABP B-55/BIG 6-13: Amendment 2, Version Date: October 19, 2015 (posted to CTSU)

NRG-GY003: Amendments 1 and 2, Version Date: February 2, 2016

RTOG 0920: Amendment 10, Version Date: January 25, 2016

NSABP B-55/BIG 6-13:A slide set from the NSABP B-55/BIG 6-13 Protocol Workshop provided on January 23, 2016, during the NRG Oncology Meeting has been posted to the Nurses-CRAs/Education and Training page on the NRG Oncology website.


Safety updates have been issued for GOG legacy studies. For details, please see the GOG Weekly Mailing page.

Safety updates have been issued for NSABP legacy studies. For details, please see the NSABP Members’ Area or the E-mail Distributions page and the CTSU website.

Safety updates have been issued for RTOG legacy studies. For details, please see the RTOG General Broadcast page

The Pharmaceutical Management Branch (PMB) has issued an updated IB for the following NRG Oncology studies:
Nivolumab: NRG-GY002, NRG-GY003, NRG-BN002
All investigator’s receiving this agent from PMB for an NCI-sponsored trial have already received a copy of this IB directly from PMB. Contact PMB at IBCOORDINATOR@MAIL.NIH.GOV to obtain a copy of this IB.

Patricia A. Ganz, MD, to receive ASCO's Inaugural Joseph V. Simone Award and Lecture
Dr. Patricia Ganz will receive the American Society of Clinical Oncology's (ASCO) first annual Joseph V. Simone Award and Lecture for Excellence in Quality and Safety in the Care of Patients with Cancer. She will accept the award and present the keynote lecture at the 2016 ASCO Quality Care Symposium on February 26 in Phoenix, AZ. Dr. Ganz, distinguished professor at the UCLA Fielding School of Public Health and David Geffen School of Medicine, and Director of Cancer Prevention and Control Research at the UCLA Jonsson Comprehensive Cancer Center, is a co-chair of NRG Oncology's Patient Centered Outcomes Research Committee and a member of the NCORP Steering Committee. Read more

2015 Accrual Report Follow-up
By now you should have received your NRG Oncology accrual report for calendar year 2015. This report was sent to the Contact PI and Lead RA of each network. If you have not received the report, please check your spam/junk folders to make sure it was not routed there. If you have any questions or concerns, please send them to support@nrgoncology.org.

Please note the following upcoming meeting and abstract submission deadline dates.

Upcoming Meetings
Society of Gynecologic Oncology (SGO); Mar 19-22, 2016; San Diego, CA

Society of Surgical Oncology (SSO); Mar 2-5, 2016; Boston, MA

St. Gallen GI Cancer Conference; Mar 10-12, 2016; St Gallen, Switzerland

United States and Canadian Academy of Pathology (USCAP); Mar 12-18, 2016; Seattle, WA

Upcoming abstract submission deadlines
American Association of Physicists in Medicine (AAPM) Jul 31-Aug 4, 2016; Washington DC; due to publications committee Feb 25, 2016; meeting abstract submission deadline Mar 10, 2016

College of American Pathologists (CAP) Sep 25-28, 2016; Las Vegas, NV; due to publications committee Feb 26, 2016; meeting abstract submission deadline Mar 11, 2016

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.

Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103